Episode Details

Back to Episodes
Australia TGA Device Classification Rules: Saline Flush Syringes Reclassified to Class IIa

Australia TGA Device Classification Rules: Saline Flush Syringes Reclassified to Class IIa

Published 1 month ago
Description
Australia's Therapeutic Goods Administration (TGA) has introduced a new classification rule, Clause 2.2, that reclassifies non-invasive devices containing only saline for flushing or maintaining another device, such as pre-filled saline syringes, to Class IIa. This episode details the scope of the new rule, the critical compliance date of September 7, 2026, for new applications, and the five-year transition period for devices already on the Australian Register of Therapeutic Goods (ARTG). We provide practical steps for manufacturers to ensure compliance with these updated TGA device classification rules. Key Questions: - What is the new TGA Clause 2.2 and which specific combination products does it affect? - Why have pre-filled saline flush syringes been reclassified to Class IIa in Australia? - What is the effective date for new device applications to comply with this rule? - How long is the transition period for existing devices already on the ARTG? - What are the immediate impacts on a manufacturer's Quality Management System (QMS)? - What evidence is required for a Class IIa submission to the TGA? - How does this change align Australian regulations with other global markets? - What are the first steps your regulatory team should take to prepare for this change? Sources: - https://www.nationaltribune.com.au/updated-classification-rules-for-certain-combination-products/ - https://www.tga.gov.au/news/news/updated-classification-rules-certain-combination-products How Pure Global can help: Pure Global provides comprehensive regulatory consulting for MedTech and IVD companies seeking to navigate complex market changes like the TGA's new classification rules. Our experts offer end-to-end support, including developing regulatory strategies for new submissions, creating transition plans for existing products, and compiling Class IIa technical dossiers. By leveraging our local Australian expertise and advanced AI tools, we streamline the submission process, ensuring your products meet all TGA requirements efficiently. Whether you're launching a new device or managing a legacy portfolio, we can help you maintain compliance and secure your market presence in Australia. Contact us at info@pureglobal.com, visit https://pureglobal.com, or explore our free AI tools and device database at https://pureglobal.ai.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us